tiprankstipranks
Cynata Therapeutics Limited (CYYNF)
OTHER OTC:CYYNF

Cynata Therapeutics Limited (CYYNF) Technical Analysis

3 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
12Bullish
0Neutral
3Bearish
Technical Analysis Consensus
Buy
2Bullish
0Neutral
1Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Cynata Therapeutics Limited’s (CYYNF) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Cynata Therapeutics Limited is a Buy.
Cynata Therapeutics Limited’s (CYYNF) 20-Day exponential moving average is 0.11, while Cynata Therapeutics Limited’s (CYYNF) share price is $0.11, making it a Buy.
Cynata Therapeutics Limited’s (CYYNF) 50-Day exponential moving average is 0.10, while Cynata Therapeutics Limited’s (CYYNF) share price is $0.11, making it a Buy.

Cynata Therapeutics Limited (CYYNF) Pivot Points

May 28, 2024, 01:08 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.11
0.11
0.11
0.11
0.11
0.11
0.11
Fibonacci
0.11
0.11
0.11
0.11
0.11
0.11
0.11
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cynata Therapeutics Limited (CYYNF) Moving Averages

May 28, 2024, 01:08 AM
Period
Simple
Exponential
MA5
0.11Sell
0.11Buy
MA10
0.11Sell
0.11Buy
MA20
0.11Buy
0.11Buy
MA50
0.10Buy
0.10Buy
MA100
0.08Buy
0.09Buy
MA200
0.08Buy
0.10Buy
Cynata Therapeutics Limited’s (CYYNF) 10-Day exponential moving average is 0.11, while Cynata Therapeutics Limited’s (CYYNF) share price is $0.11, making it a Buy.
Cynata Therapeutics Limited’s (CYYNF) 100-Day exponential moving average is 0.09, while Cynata Therapeutics Limited’s (CYYNF) share price is $0.11, making it a Buy.
Cynata Therapeutics Limited’s (CYYNF) stock price is $0.11 and Cynata Therapeutics Limited’s (CYYNF) 50-day simple moving average is 0.10, creating a Buy signal.
Cynata Therapeutics Limited’s (CYYNF) stock price is $0.11 and Cynata Therapeutics Limited’s (CYYNF) 100-day simple moving average is 0.08, creating a Buy signal.
Cynata Therapeutics Limited’s (CYYNF) stock price is $0.11 and Cynata Therapeutics Limited’s (CYYNF) 200-day simple moving average is 0.08, creating a Buy signal.

Cynata Therapeutics Limited (CYYNF) Technical Indicators

May 28, 2024, 01:08 AM
Name
Value
Implied Action
RSI (14)
99.99
Sell
STOCH (9,6)
0.00
-
STOCHRSI (14)
0.00
-
MACD (12,26)
<0.01
Buy
CCI (14)
0.00
-
ATR (14)
<0.01
-
ROC
0.00
-
Bull/Bear Power (13)
<0.01
Buy
Cynata Therapeutics Limited’s (CYYNF) Relative Strength Index (RSI) is 99.99, creating a Sell signal.

FAQ

Is CYYNF a Buy, Hold, or Sell?
Based on CYYNF’s technical indicators, CYYNF is a Strong Buy.
    What is CYYNF’s RSI (14)?
    CYYNF’s RSI (14) is 99.99, which suggests CYYNF is a Sell.
      What is CYYNF’s MACD?
      CYYNF’s MACD is <0.01, which suggests CYYNF is a Buy.
        What is CYYNF’s 5-day moving average?
        CYYNF’s 5-day moving average is 0.11, which suggests CYYNF is a Sell.
          What is CYYNF’s 20-day moving average?
          CYYNF 20-day moving average is 0.11, which suggests CYYNF is a Buy.
            What is CYYNF’s 50-day moving average?
            CYYNF’s 50-day moving average is 0.10, which suggests CYYNF is a Buy.
              What is CYYNF’s 200-day moving average?
              CYYNF’s 200-day moving average is 0.08, which suggests CYYNF is a Buy.
                What is CYYNF’s Williams % R (14)?
                Currently, no data Available
                What is CYYNF’s CCI (14)?
                Currently, no data Available
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis